Drug repurposing. (2022)

• Record Type: Book
• Further Information: Note: Edited by David Cavalla.
• Editors: Cavalla, David
• Contents: Introduction and Historical Overview of Drug Repurposing Opportunities; Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases; The Role of Clinical Medicine; Role of Industry; Collaboration Models for Repurposing; Screening Technologies; Cheminformatics Data Mining and Modeling for Drug Repurposing; Using Artificial Intelligence for Drug Repurposing; Field Discoveries (Case Reports); Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy; Harnessing the Potential of Early Access; Adapting Payers’ and Producers’ Incentives to Drug Repurposing; Intellectual Property Considerations; Regulatory Considerations and Strategies for Drug Repositioning; Future Perspectives in Drug Repurposing
• Edition: 1st
• Publisher Details: Cambridge : Royal Society of Chemistry
• Publication Date: 2022
• Extent: 1 online resource
• Subjects: 615.19; Drug development
• Languages: English
• ISBNs: 9781839163401; 9781839163418
• Related ISBNs: 9781788019033
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.